Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gastric Cancer
  Free Subscription

Articles published in
Cancer Lett
    October 2026
  1. ZOU G, Yoshimura K, Fan Y, Zeng L, et al
    Pharmacologic inhibition of SOX9-CDK4 by CYD-4-61 impairs gastric adenocarcinoma growth and amplifies anti-PD-1 response.
    Cancer Lett. 2026;659:218777.
    >> Share

    September 2026
  2. LI Q, Yang J, Cao L, Wang Q, et al
    Cancer-associated fibroblast-enriched TAGLN orchestrates HGF/c-MET-dependent transcriptional reprogramming in gastric cancer.
    Cancer Lett. 2026;660:218832.
    >> Share

    August 2026
  3. HUANG Y, Xu X, Jiang N, Zhang W, et al
    Non-Invasive Strategy for Gastric Cancer Detection: Integration of Cell-free DNA Fragmentomics and Protein Biomarkers.
    Cancer Lett. 2026 Aug 31:218811. doi: 10.1016/j.canlet.2026.218811.
    >> Share

    May 2026
  4. CHU H, Liu X, Zhuang X, Wang F, et al
    Exosomal circFXR1 drives immune evasion and tumor progression through dual regulation of PD-L1 and mTOR signaling in gastric cancer.
    Cancer Lett. 2026;655:218625.
    >> Share

  5. KAKKAT S, Suman P, Goswami S, Kola B, et al
    Angiotensin II Type 1 Receptor Blockade Inhibits Gastric Cancer Metastasis Through Tight Junction Restoration.
    Cancer Lett. 2026 May 2:218530. doi: 10.1016/j.canlet.2026.218530.
    >> Share

    April 2026
  6. YANG J, You J, Li T, Zhang Z, et al
    Excessive lymph node dissection compromises efficacy of postsurgical immunotherapy for gastric cancer:A multicenter retrospective study.
    Cancer Lett. 2026 Apr 28:218550. doi: 10.1016/j.canlet.2026.218550.
    >> Share

    March 2026
  7. JIANG Y, Zhao Z, Ma L, Shao X, et al
    Exosomal circUBR5 drives metastasis and chemoresistance in gastric signet-ring cell carcinoma by reprogramming cholesterol metabolism through the hsa-miR-1208/CYP19A1 axis and ACAT1 upregulation.
    Cancer Lett. 2026;641:218279.
    >> Share

  8. CHEN H, Cai Q, Chen Y, Huang J, et al
    Blocking CEMIP2-Mediated Low-Molecular-Weight Hyaluronic Acid -TGFbeta Signaling Inhibits Chemotherapy-Associated Lymphatic Metastasis in Gastric Cancer.
    Cancer Lett. 2026 Mar 28:218462. doi: 10.1016/j.canlet.2026.218462.
    >> Share

  9. LIN Z, Gao Y, Zhang Q, Yang S, et al
    Hypoxia-driven phase separation of the PABP1/eIF4B complex forms stress granules and activates ChaC2 translation to promote polyunsaturated lipids-supported peritoneal metastasis in gastric cancer.
    Cancer Lett. 2026 Mar 2:218392. doi: 10.1016/j.canlet.2026.218392.
    >> Share

    January 2026
  10. ZHAO L, Chen Z, Zhang F, Zhang F, et al
    Changing Landscape in Stage, Treatment and Survival of Gastric Cancer in China 1998-2022: Insights of 40,158 patients from the National Gastric Cancer Cohort.
    Cancer Lett. 2026 Jan 23:218261. doi: 10.1016/j.canlet.2026.218261.
    >> Share

  11. ZHANG J, Wang J, Guo Q, Wang Y, et al
    Corrigendum to "LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells" [Cancer Lett. 317 (2012) 24-32].
    Cancer Lett. 2026 Jan 12:218250. doi: 10.1016/j.canlet.2026.218250.
    >> Share

    December 2025
  12. KANG S, Seol D, Lee J, Bang C, et al
    Extrachromosomal DNA amplifications exhibit distinct molecular characteristics and prognostic implications in gastric cancer.
    Cancer Lett. 2025 Dec 9:218214. doi: 10.1016/j.canlet.2025.218214.
    >> Share

  13. URBANOVA M, Viol F, Ruiz-Canas L, Koniaris E, et al
    Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma.
    Cancer Lett. 2025;634:218033.
    >> Share

    October 2025
  14. YANG Y, Jia X, Peng Y, Lu S, et al
    Phosphorylation of MSX1 controls tumorigenesis and bone development through targeting FBXW7 degradation.
    Cancer Lett. 2025;631:217948.
    >> Share

  15. YAZDI N, Pourjamal N, Katainen R, Vaananen J, et al
    Drug-tolerant persisting polyploid giant cancer cells mediate resistance to HER2-targeting antibody-drug conjugates.
    Cancer Lett. 2025;630:217900.
    >> Share

    August 2025
  16. WU QN, Liao YF, Lu YX, Wang Y, et al
    Corrigendum to "Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance" [Cancer Lett. (2018) 412 243-255].
    Cancer Lett. 2025 Aug 19:217983. doi: 10.1016/j.canlet.2025.217983.
    >> Share

    July 2025
  17. LEE CK, Park S, Lee Y, Yun C, et al
    Efficacy of the first-line immune checkpoint inhibitor plus chemotherapy for gastroesophageal cancer: A meta-analysis of phase III trials including unreported PD-L1 subgroups.
    Cancer Lett. 2025;623:217718.
    >> Share

  18. CHENG S, Luo Y, Dong X, Liu MY, et al
    Advanced Ensemble Staking Model Employing cfDNA Fragmentation for Early Detection of Esophageal and Gastric Cancer.
    Cancer Lett. 2025 Jul 23:217945. doi: 10.1016/j.canlet.2025.217945.
    >> Share

  19. BU F, Ding G, Yang L, Wu Y, et al
    Lectin-affinity glycosylation pattern analysis of plasma extracellular vesicles: An all-in-one clinical assessment for gastric cancer diagnosis and treatment.
    Cancer Lett. 2025;631:217929.
    >> Share

  20. HUANG W, Wang X, Zhong R, Li Z, et al
    Multimodal Radiopathomics Signature for Prediction of Response to Immunotherapy-based Combination Therapy in Gastric Cancer Using Interpretable Machine Learning.
    Cancer Lett. 2025 Jul 15:217930. doi: 10.1016/j.canlet.2025.217930.
    >> Share

  21. SONG S, Fan Y, Zou G, Huo L, et al
    KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB.
    Cancer Lett. 2025;621:217695.
    >> Share

    June 2025
  22. GERAKOPOULOS V, Ramos C, Muller C, Walterskirchen N, et al
    Single-cell transcriptomic analysis identifies tissue-specific fibroblasts as the main modulators of myeloid cells in peritoneal metastasis of different origin.
    Cancer Lett. 2025;620:217678.
    >> Share

  23. PENG J, Yin Y, Liu X, Deng C, et al
    CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation.
    Cancer Lett. 2025;629:217886.
    >> Share

  24. YU S, Chen M, Jiang K, Chen C, et al
    CircSRPK1 mediated by the exon junction complex promotes gastric cancer progression by interacting with hnRNP A2B1 to regulate RON mRNA alternative splicing.
    Cancer Lett. 2025 Jun 16:217879. doi: 10.1016/j.canlet.2025.217879.
    >> Share

  25. SHI Y, Zhao Z, Zhou S, Zhou Z, et al
    CHD4 drives gastric cancer metastasis via MYH9/GSK3beta/beta-catenin axis and WNT/EMT pathway activation.
    Cancer Lett. 2025;628:217813.
    >> Share

    May 2025
  26. JIN Z, Zhang C, Shen L, Cao Y, et al
    Harnessing exosomes: From tumor immune escape to therapeutic innovation in gastric cancer immunotherapy.
    Cancer Lett. 2025;626:217792.
    >> Share

    April 2025
  27. LI W, Wei H, Liu J, Zhao Z, et al
    Exosomal Biglycan Promotes Gastric Cancer Progression via M2 Polarization and CXCL10-Mediated JAK/STAT1 Activation.
    Cancer Lett. 2025 Apr 29:217758. doi: 10.1016/j.canlet.2025.217758.
    >> Share

  28. LIU Q, Yu M, Lin Z, Wu L, et al
    COL1A1-positive endothelial cells promote gastric cancer progression via the ANGPTL4-SDC4 axis driven by endothelial-to-mesenchymal transition.
    Cancer Lett. 2025;623:217731.
    >> Share

    March 2025
  29. LUO D, Wang H, Liu J, Chen X, et al
    Combined MDM2 and G2/M checkpoint inhibition induces synergistic antitumor response in gastric signet-ring cell carcinoma.
    Cancer Lett. 2025;613:217500.
    >> Share

  30. YANG D, Zhang X, Hu Z, Sun Q, et al
    Organoid-based single cell sequencing revealed the lineage evolution during docetaxel treatment in gastric cancer.
    Cancer Lett. 2025 Mar 19:217617. doi: 10.1016/j.canlet.2025.217617.
    >> Share

  31. WEI R, Song J, Liu C, Zhao Z, et al
    FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity.
    Cancer Lett. 2025;612:217475.
    >> Share

    February 2025
  32. TOJJARI A, Idrissi YA, Saeed A
    Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2.
    Cancer Lett. 2025;611:217362.
    >> Share

  33. LI N, Tong H, Hou W, Liu Q, et al
    Neural-cancer Crosstalk: Reciprocal Molecular Circuits Driving Gastric Tumorigenesis and Emerging Therapeutic Opportunities.
    Cancer Lett. 2025 Feb 25:217589. doi: 10.1016/j.canlet.2025.217589.
    >> Share

  34. XU X, Huang Z, Han H, Yu Z, et al
    N(7)-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation.
    Cancer Lett. 2025;615:217566.
    >> Share

  35. LI X, Lu J, Chen F, Yuan J, et al
    Comprehensive proteomic analysis and multidimensional model construction of peritoneal metastasis in gastric cancer.
    Cancer Lett. 2025 Feb 4:217509. doi: 10.1016/j.canlet.2025.217509.
    >> Share

    December 2024
  36. MAK TK, Li K, Zhao Z, Wang K, et al
    m6A demethylation of NNMT in CAFs promotes gastric cancer progression by enhancing macrophage M2 polarization.
    Cancer Lett. 2024 Dec 24:217422. doi: 10.1016/j.canlet.2024.217422.
    >> Share

  37. TSUTSUMI C, Ohuchida K, Tsutsumi H, Shimada Y, et al
    TIM3 on natural killer cells regulates antibody-dependent cellular cytotoxicity in HER2-positive gastric cancer.
    Cancer Lett. 2024 Dec 23:217412. doi: 10.1016/j.canlet.2024.217412.
    >> Share

  38. YUAN J, Lu J, Zhu J, Chen F, et al
    LncRNA FIRRE drives gastric cancer progression via ZFP64-mediated TUBB3 promoter activation.
    Cancer Lett. 2024 Dec 18:217398. doi: 10.1016/j.canlet.2024.217398.
    >> Share

    November 2024
  39. YOSHIMURA K, Zou G, Fan Y, Yamashita K, et al
    HSP90 Inhibitor AUY922 Suppresses Tumor Growth and Modulates Immune Response through YAP-TEAD Pathway Inhibition in Gastric Cancer.
    Cancer Lett. 2024 Nov 25:217354. doi: 10.1016/j.canlet.2024.217354.
    >> Share

    July 2024
  40. YANG R, Kwan W, Du Y, Yan R, et al
    Corrigendum to "Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids" [Cancer Lett. 598 (2024) 217106].
    Cancer Lett. 2024 Jul 30:217127. doi: 10.1016/j.canlet.2024.217127.
    >> Share

  41. YANG R, Kwan W, Du Y, Yan R, et al
    Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids.
    Cancer Lett. 2024 Jul 9:217106. doi: 10.1016/j.canlet.2024.217106.
    >> Share

  42. GOMAA A, Maacha S, Peng D, Soutto M, et al
    SOX9 is regulated by AURKA in response to Helicobacter pylori infection via EIF4E-mediated cap-dependent translation.
    Cancer Lett. 2024;593:216939.
    >> Share

    June 2024
  43. LIM SH, Saluja A, Vickers S, Hong JY, et al
    The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: a Phase I trial.
    Cancer Lett. 2024 Jun 10:217041. doi: 10.1016/j.canlet.2024.217041.
    >> Share

    May 2024
  44. LEI T, Lin Y, Lai X, Zhang Y, et al
    ITGB5 facilitates gastric cancer metastasis by promoting TGFBR2 endosomal recycling.
    Cancer Lett. 2024;592:216953.
    >> Share

  45. XIA Y, Jiang T, Li Y, Gu C, et al
    circVAPA-rich small extracellular vesicles derived from gastric cancer promote neural invasion by inhibiting SLIT2 expression in neuronal cells.
    Cancer Lett. 2024 May 5:216926. doi: 10.1016/j.canlet.2024.216926.
    >> Share

    April 2024
  46. ZHANG J, Fu L, Wang H, Yonemura A, et al
    RAC1-mediated Integrin alpha-6 expression in E-cadherin-deficient gastric cancer cells promotes interactions with the stroma and peritoneal dissemination.
    Cancer Lett. 2024 Apr 17:216901. doi: 10.1016/j.canlet.2024.216901.
    >> Share

  47. CHEN J, Ji Y, Liu Y, Cen Z, et al
    Exhaled volatolomics profiling facilitates personalized screening for gastric cancer.
    Cancer Lett. 2024;590:216881.
    >> Share

  48. WANG L, Mao X, Yu X, Su J, et al
    FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway.
    Cancer Lett. 2024 Apr 11:216841. doi: 10.1016/j.canlet.2024.216841.
    >> Share

  49. ZHANG Y, Lin W, Yang Y, Zhu S, et al
    MEF2D facilitates liver metastasis of gastric cancer cells through directly inducing H1X under IL-13 stimulation.
    Cancer Lett. 2024 Apr 10:216878. doi: 10.1016/j.canlet.2024.216878.
    >> Share

  50. WEN W, Ertas YN, Erdem A, Zhang Y, et al
    Dysregulation of autophagy in gastric carcinoma: Pathways to tumor progression and resistance to therapy.
    Cancer Lett. 2024 Apr 5:216857. doi: 10.1016/j.canlet.2024.216857.
    >> Share

    March 2024
  51. RIEGEL G, Orvain C, Recberlik S, Spaety ME, et al
    The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanisms.
    Cancer Lett. 2024;585:216671.
    >> Share

  52. ZHAO Z, Cai Z, Zhang S, Yin X, et al
    Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer.
    Cancer Lett. 2024 Mar 25:216796. doi: 10.1016/j.canlet.2024.216796.
    >> Share

    February 2024
  53. CHANG M, Sun Q, Cui X, Wang Y, et al
    Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits Helicobacter pylori mediated gastric cancer by destabilizing DDX21.
    Cancer Lett. 2024 Feb 20:216746. doi: 10.1016/j.canlet.2024.216746.
    >> Share

  54. LIN C, Lin P, Yao H, Liu S, et al
    Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.
    Cancer Lett. 2024 Feb 14:216712. doi: 10.1016/j.canlet.2024.216712.
    >> Share

  55. LIANG B, Wu Q, Wang Y, Shi Y, et al
    Cdc42-driven endosomal cholesterol transport promotes collateral resistance in HER2-positive gastric cancer.
    Cancer Lett. 2024 Feb 7:216702. doi: 10.1016/j.canlet.2024.216702.
    >> Share

    January 2024
  56. CHEN P, Zhong X, Song Y, Zhong W, et al
    Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells.
    Cancer Lett. 2024 Jan 19:216622. doi: 10.1016/j.canlet.2024.216622.
    >> Share

  57. WU QN, Qi J, Liu ZK, Luo XJ, et al
    HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer.
    Cancer Lett. 2024 Jan 19:216643. doi: 10.1016/j.canlet.2024.216643.
    >> Share

  58. WENG N, Zhou C, Zhou Y, Zhong Y, et al
    IKZF4/NONO-RAB11FIP3 axis promotes immune evasion in gastric cancer via facilitating PD-L1 endosome recycling.
    Cancer Lett. 2024 Jan 9:216618. doi: 10.1016/j.canlet.2024.216618.
    >> Share

    November 2023
  59. WANG H, Zhou Z, Zhang J, Hao T, et al
    Pumilio1 regulates NPM3/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer.
    Cancer Lett. 2023;581:216498.
    >> Share

  60. JIANG T, Xia Y, Li Y, Lu C, et al
    TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer.
    Cancer Lett. 2023;581:216510.
    >> Share

    October 2023
  61. FENG W, Ma C, Rao H, Zhang W, et al
    Setd2 deficiency promotes gastric tumorigenesis through inhibiting the SIRT1/FOXO pathway.
    Cancer Lett. 2023 Oct 30:216470. doi: 10.1016/j.canlet.2023.216470.
    >> Share

  62. HUA H, Su T, Han L, Zhang L, et al
    LINC01226 promotes gastric cancer progression through enhancing cytoplasm-to-nucleus translocation of STIP1 and stabilizing beta-catenin protein.
    Cancer Lett. 2023 Oct 6:216436. doi: 10.1016/j.canlet.2023.216436.
    >> Share

    September 2023
  63. LI J, Feng H, Zhu J, Yang K, et al
    Gastric cancer derived exosomal THBS1 enhanced Vgamma9Vdelta2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner.
    Cancer Lett. 2023 Sep 30:216410. doi: 10.1016/j.canlet.2023.216410.
    >> Share

    August 2023
  64. MAO D, Zhou Z, Chen H, Liu X, et al
    Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer.
    Cancer Lett. 2023 Aug 15:216351. doi: 10.1016/j.canlet.2023.216351.
    >> Share

  65. ANDREUCCI E, Biagioni A, Peri S, Versienti G, et al
    The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs.
    Cancer Lett. 2023 Aug 5:216338. doi: 10.1016/j.canlet.2023.216338.
    >> Share

    July 2023
  66. ZHAO P, Yuan F, Xu L, Jin Z, et al
    HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex.
    Cancer Lett. 2023 Jul 7:216305. doi: 10.1016/j.canlet.2023.216305.
    >> Share

    May 2023
  67. CHEN Z, Xu P, Wang X, Li Y, et al
    MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer.
    Cancer Lett. 2023;565:216235.
    >> Share

    April 2023
  68. LI M, Mei YX, Wen JH, Jiao YR, et al
    Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
    Cancer Lett. 2023;559:216104.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016